RxDoctor Payments Data

Haley Goulson, PA

Physician Assistant · Dekalb, ILNPI 1417283938

Payments from drug & device makers

$1,018in general payments, 2019–2025

Across 17 payments — averaging $59.88 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Lilly USA, LLC$241
  • E.r. Squibb & Sons, L.L.C.$228
  • Johnson & Johnson$166
  • Incyte Corporation$99
  • Jazz Pharmaceuticals Inc.$89
  • Stemline Therapeutics Inc.$83
  • plus $112 from 4 others

What the payments were for

  • Food & beverage$66665%
  • Education$35235%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,018 in reported general payments places this provider in the 70th percentile of 3,912 physician assistant providers in Illinois.

See all physician assistant providers in Illinois

Medicare billing

Part B allowed, 2024
$60,414
Medicare patients
262
Services billed
615

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
CabometyxCabozantinib S-Malate29$650,069
EliquisApixaban69$59,512
XareltoRivaroxaban31$31,019
Acyclovir109$1,438
Ondansetron OdtOndansetron35$937
Prochlorperazine Maleate51$544
ValacyclovirValacyclovir Hcl17$462
Gabapentin24$382
Dexamethasone15$266
Hydroxyurea20$264
Potassium Chloride31$256
Olanzapine12$242
Doxycycline Hyclate14$192
Prednisone36$173
Pantoprazole Sodium15$147

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Johnson & JohnsonXarelto$166$31,01931 claims
Lilly USA, LLCOlanzapine$241$24212 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 3,912 physician assistant providers in Illinois.

Other physician assistant in Dekalb

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →